SCHEMBL1634840

SCHEMBL1634840

COc1cc(OC)c(/C=C/[S+]([O-])Cc2ccc(OC)c(OC(=O)c3cc(N)cc(N)c3)c2)c(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.40
TAS2R14 Q9NYV8 1/20 0.38
PRSS1 P07477 1/20 0.38
ACR P10323 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PLK1 P53350 4/20 0.38
MAOA P21397 2/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 2/20 0.37
NPC1 O15118 1/20 0.37
MET P08581 1/20 0.37
NQO2 P16083 1/20 0.37
FECH P22830 1/20 0.37
CLK3 P49761 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634386 0.92 ABCG2 (0.43) ABCG2TAS2R14PRSS1ACRKMT2A
SCHEMBL1634857 0.88 KMT2A (0.52) ABCG2TAS2R14PRSS1ACRKMT2A
SCHEMBL1634855 0.88 KMT2A (0.52) ABCG2TAS2R14PRSS1ACRKMT2A
SCHEMBL1635408 0.87 ABCG2 (0.42) ABCG2TAS2R14CYP3A4PLK1MAOA
SCHEMBL1635404 0.87 ABCG2 (0.42) ABCG2TAS2R14CYP3A4PLK1MAOA
SCHEMBL4657805 0.85 ALDH1A1 (0.42) ABCG2KMT2AMEN1TDP1L3MBTL1
SCHEMBL1635532 0.85 ALDH1A1 (0.42) ABCG2KMT2AMEN1TDP1L3MBTL1
SCHEMBL1634672 0.85 ABCG2 (0.40) ABCG2TAS2R14CYP3A4PLK1MAOA
SCHEMBL1634452 0.84 PLK1 (0.42) ABCG2CYP3A4PLK1MAOACYP1A1
SCHEMBL1634448 0.84 PLK1 (0.42) ABCG2CYP3A4PLK1MAOACYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP claimed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US claimed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US claimed
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 ABCG2 1761/4885TAS2R14 3675/4885PRSS1 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.